Carson Allaria Wealth Management, Ltd. Bristol Myers Squibb CO Transaction History
Carson Allaria Wealth Management, Ltd.
- $169 Million
- Q3 2024
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 1,556 shares of BMY stock, worth $90,605. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,556
Previous 1,556
-0.0%
Holding current value
$90,605
Previous $64,000
25.0%
% of portfolio
0.05%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,533Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.24 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.41 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.54 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.55 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $124B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...